Drug therapy improves treatment of head and neck cancers
This article was originally published in Clinica
Executive Summary
Adding weekly chemotherapy to radiation therapy for head and neck cancers increased three-year survival rates from as little as 20% to nearly 50%, according to a University of Maryland study. The findings are preliminary, however, and must be confirmed in a larger, randomised trial of the technique, the researchers warned at the American Society for Therapeutic Radiology meeting in San Antonio, Texas last week.